Jun Ke

1.1k citations
48 papers · 609 · 2 hit papers · h-index 11

Impact in

    • HER2/EGFR in Cancer Research
    • Cancer-related molecular mechanisms research
    • MicroRNA in disease regulation
    • Breast Cancer Treatment Studies

Papers in

Jun Ke

44 papers receiving 604 citations

Jun Ke's Hit Papers

Trastuzumab deruxtecan (T-DXd) vs physician’s choice of chemotherapy (TPC) in patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor 2 (HER2)-low or HER2-ultralow metastatic breast cancer (mBC) with prior endocrine therapy (ET): Primary results from DESTINY-Breast06 (DB-06). 2024 · 60 citations
600+1Years since publication50100150

Peers

Jun Ke
Comparison fields: 5 of 84
  • Oncology 184
  • Cancer Research 70
  • Pulmonary and Respiratory Medicine 90
  • Radiology, Nuclear Medicine and Imaging 64
  • Developmental Neuroscience 11
Replace Ping‐Ying Chang with:
Ping‐Ying Chang Taiwan
Romina Tripaldi Italy
Mathias Zimmermann Germany
Bing Sun China
Hui Yan China
Dongfeng Han China
Kiyonori Kai Japan
Yulan Gong United States
Jinxiu Lin China
Jun Ke relative to Ping‐Ying Chang Taiwan Ping‐Ying Chang's profile →
Citations per field
00.5×10×16×
Ping‐Ying Chang · 1×
Citations per year

Countries citing papers authored by Jun Ke

Since Specialization
Citations

This map shows the geographic impact of Jun Ke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Ke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Ke more than expected).

Fields of papers citing papers by Jun Ke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Ke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Ke. The network helps show where Jun Ke may publish in the future.

Co-authors

The 25 scholars most cited alongside Jun Ke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jun Ke Line = papers co-authored together Jun Ke links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
Hit paper breakdown →
2024182
2
Trastuzumab deruxtecan (T-DXd) vs physician’s choice of chemotherapy (TPC) in patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor 2 (HER2)-low or HER2-ultralow metastatic breast cancer (mBC) with prior endocrine therapy (ET): Primary results from DESTINY-Breast06 (DB-06).
Hit paper breakdown →
202460
3 201651
4 202235
5 201730
6 202225
7 202118
8 201915
9 202414
10 202411
11 202311
12 202210
13 202210
14 20179
15 20188
16 20228
17 20028
18 20247
19 20237
20 20237

About Jun Ke

Jun Ke is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Oncology, having authored 48 papers that have together received 609 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (3 papers), Cancer-related molecular mechanisms research (3 papers), Circular RNAs in diseases (3 papers), MicroRNA in disease regulation (3 papers), Birth, Development, and Health (3 papers), Cardiac electrophysiology and arrhythmias (2 papers), Respiratory Support and Mechanisms (2 papers) and interferon and immune responses (2 papers). The work is most often cited by research in Oncology (184 citations), Cancer Research (70 citations), Pulmonary and Respiratory Medicine (90 citations), Radiology, Nuclear Medicine and Imaging (64 citations) and Developmental Neuroscience (11 citations). Jun Ke has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Aditya Bardia, William Jacot, Gargi Patel, Rebecca Dent, Seock‐Ah Im, Kan Yonemori, Laura Biganzoli, Cristina Saura, Joohyuk Sohn and Christelle Lévy. Their work appears in journals such as Virology Journal, Journal of Clinical Oncology, PLoS ONE, Biochemical Pharmacology and Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact